Overcoming ELDR-mediated cancer cell survival in vitro and in vivo via sphingomyelin-driven TRPML1 inactivation and TFEB suppression through lysosomal HSP70 targeting
Open Access
- 5 December 2025
- journal article
- Published by Elsevier in Pharmacological Research
- Vol. 222, 108050
Abstract
No abstract availableKeywords
Funding Information
- Guizhou Provincial Natural Science Foundation (QKHRCCXTD [2025]049)
- National Natural Science Foundation of China (82373909)
- National Natural Science Foundation of China (82173847)
This publication has 42 references indexed in Scilit:
- Emerging roles of lysosome homeostasis (repair, lysophagy and biogenesis) in cancer progression and therapyCancer Letters, 2023
- Targeting lysosomal HSP70 induces acid sphingomyelinase‐mediated disturbance of lipid metabolism and leads to cell death in T cell malignanciesClinical and Translational Medicine, 2023
- Cholesterol-dependent molecular mechanisms contribute to cationic amphiphilic drugs’ prevention of silica-induced inflammationEuropean Journal of Cell Biology, 2023
- Simultaneous targeting of mitochondrial Kv1.3 and lysosomal acid sphingomyelinase amplifies killing of pancreatic ductal adenocarcinoma cells in vitro and in vivoJournal of Molecular Medicine, 2023
- Targeting autophagy in cancerCancer, 2018
- Emerging Roles for the Lysosome in Lipid MetabolismTrends in Cell Biology, 2017
- Autophagy and Tumor MetabolismCell Metabolism, 2017
- TRIMs and Galectins Globally Cooperate and TRIM16 and Galectin-3 Co-direct Autophagy in Endomembrane Damage HomeostasisDevelopmental Cell, 2016
- Imaging local sphingomyelin-rich domains in the plasma membrane using specific probes and advanced microscopyBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2014
- Amiodarone impairs trafficking through late endosomes inducing a Niemann-Pick C-like phenotypeBiochemical Pharmacology, 2011